Likewise, a DGAT1 inhibitor (T-863 or PF-04620110) significantly decreased the total number of small and large LDs in breast cancer MCF-7 cells, suggesting that DGAT1 and DGAT2 interact in the process of LD formation in tumor cells [35]. Here, DGAT2 is linked to breast cancer.